A Phase 1, Randomized, Open Label, Single Dose, 2-Period Crossover Study To Evaluate The Effect Of Food On The Pharmacokinetics Of Tofacitinib Modified Release (MR) 11 Mg Tablets In Healthy Western And Japanese Volunteers

Trial Profile

A Phase 1, Randomized, Open Label, Single Dose, 2-Period Crossover Study To Evaluate The Effect Of Food On The Pharmacokinetics Of Tofacitinib Modified Release (MR) 11 Mg Tablets In Healthy Western And Japanese Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Mar 2016

At a glance

  • Drugs Tofacitinib (Primary)
  • Indications Ankylosing spondylitis; Atopic dermatitis; Crohn's disease; Dry eyes; Juvenile rheumatoid arthritis; Plaque psoriasis; Psoriatic arthritis; Rheumatoid arthritis; Ulcerative colitis
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 11 Mar 2016 Results from this and other phase I trial, published in the Journal of Clinical Pharmacology.
    • 09 Jul 2014 According to the ClinicalTrials.gov record, status changed from recruiting to completed.
    • 09 Jun 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 May 2014 to 1 Jun 2014.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top